. Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease. Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):563-570. Epub 2020 Sep 20 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.